Oppenheimer Has Lowered Expectations for OnKure Therapeutics (NASDAQ:OKUR) Stock Price
OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) had its price objective lowered by Oppenheimer from $35.00 to $30.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Several other analysts have also recently commented on OKUR. Leerink Partnrs upgraded shares of OnKure […]
OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) had its price objective lowered by Oppenheimer from $35.00 to $30.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Several other analysts have also recently commented on OKUR. Leerink Partnrs upgraded shares of OnKure […]
